Ligand id: 8967

Name: galcanezumab

Compound class Antibody
International Nonproprietary Names
INN number INN
10277 galcanezumab
clone III | LY-2951742 | LY2951742
Galcanezumab (LY2951742) is an investigational monoclonal antibody targeting calcitonin A and B (CALCA a.k.a. α-CGRP and CALCB a.k.a. β-CGRP respectively), being investigated for its potential anti-migraine and analgesic actions.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with peptides claimed in patent WO2007076336 [1].
Database Links
Specialist databases
IMGT/mAb-DB 609
Other databases
GtoPdb PubChem SID 310264747
Search PubMed clinical trials galcanezumab
Search PubMed titles galcanezumab
Search PubMed titles/abstracts galcanezumab